Methods for determining the risk of suffering from preeclampsia

The method uses plasma RNA transcripts and machine learning to predict preeclampsia risk via gene signatures, addressing the lack of early and non-invasive diagnosis, enabling timely clinical intervention.

WO2026114972A1PCT designated stage Publication Date: 2026-06-04IPREMOM PREGNANCY HEALTHCARE DIAGNOSTICS SL
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2025/084391
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-26
Filing Date
2025-11-26
Publication Date
2026-06-04

Smart Images

  • Figure IMGF000019_0001
    Figure IMGF000019_0001
  • Figure IMGF000034_0001
    Figure IMGF000034_0001
  • Figure IMGF000035_0001
    Figure IMGF000035_0001
Patent Text Reader

Abstract

The present invention refers to an in vitro method for the determination of the risk of a subject suffering of preeclampsia as well as computer implemented methods thereof.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Method of Preparing a Nucleic Acid Library

    US20130203606A1

  • Markers used for diagnosis of delayed preeclampsia

    CN112126683A

  • Gene combinations associated with early-onset severe preeclampsia and their applications

    CN114822682B

  • Detection marker and application thereof

    CN118028446A

  • Marker and device for predicting preeclampsia

    CN118028447A